Core Insights - New Earth Resources Corp. has joined the Critical Minerals Institute (CMI), enhancing its engagement in the critical minerals sector [1][3][4] Industry Overview - The Critical Minerals Institute aims to provide insights into the strategic importance, sustainability, and value of critical minerals, which are essential for technological innovation and industrial development [2] - CMI offers educational programs, masterclasses, a weekly Critical Minerals Report, and networking events to connect industry leaders, investors, and experts [2] Company Developments - Membership in CMI grants New Earth access to a global network of industry professionals and potential partners, allowing the company to stay informed about emerging trends and regulatory developments [3] - The CEO of New Earth emphasized that the insights and resources from CMI will support the company's exploration initiatives and strategic decision-making [4] Company Profile - New Earth Resources Corp. is a Canadian mineral exploration company focused on acquiring and developing advanced and early-stage exploration projects, with its flagship project being the Lucky Boy Uranium Property in Arizona, USA [4] - The company holds a 100% interest in the Lucky Boy project, which includes 14 Lode Claims over approximately 273 acres, and has a history of uranium production in the 1950s and 1970s [4] - Additionally, New Earth has options to acquire interests in projects prospective for rare earth elements, including the SL Project in Quebec and the Red Wine Rare Earth Project in Labrador [5]

Core Viewpoint - Kandi Technologies Group, Inc. has entered a three-year strategic cooperation agreement with Times Qiji Green Energy Technology to enhance the deployment of heavy-truck battery swap infrastructure, marking a significant step in the company's battery swapping business [1][4]. Group 1: Strategic Cooperation - China Battery Exchange will act as a strategic supplier to Qiji Energy, focusing on the layout, equipment selection, and manufacturing of mechanical and control systems for heavy-truck battery swap stations [2]. - The agreement includes integrated delivery and after-sales services, such as spare parts support, maintenance, servicing, training, and trial operations [2][6]. - This cooperation reinforces China Battery Exchange's position within CATL's global supplier ecosystem, showcasing its technical strength and mass-production capabilities [2]. Group 2: Battery Swap Network Development - Qiji Energy aims to deploy approximately 900 battery swap stations by 2026 as part of CATL's "Ten Thousand Station Plan," with China Battery Exchange playing a crucial role in this initiative [3]. - The collaboration combines CATL's brand recognition and battery technology with China Battery Exchange's R&D and manufacturing expertise, promoting efficient and large-scale implementation of battery swap infrastructure [3]. Group 3: Company Vision and Market Position - The CEO of Kandi Technologies emphasized that this strategic cooperation is a milestone for the battery swapping business, aiming for greater standardization, scalability, and sustainable operations [4]. - Kandi Technologies has consistently viewed battery swapping as a key component of its long-term strategy, focusing on innovation and practical applications for electric vehicles [4]. - The company expects to enhance its service capabilities in new energy infrastructure and support the commercialization of its battery swapping initiatives through this cooperation [6].

Core Insights - Alvotech has reached a licensing and settlement agreement with Regeneron and Bayer, resolving all patent disputes related to its biosimilar of Eylea, which is approved for marketing in several regions [1][2][3] Group 1: Licensing and Market Entry - The settlement allows Alvotech to market and sell the biosimilar starting January 1, 2026, in the UK and Canada, and in Japan from May 1, 2026, excluding diabetic macular edema [2] - The biosimilar will be available in the European Economic Area and other countries (excluding the U.S.) from May 1, 2026, and in Japan with all approved indications from November 1, 2026 [2] Group 2: Commercial Partnerships - Alvotech's commercial partners for the Eylea biosimilar in Europe include Advanz Pharma (UK/EEA), STADA (Germany), and Biogaran (France), with Fuji Pharma Ltd. as the partner in Japan [4] - The biosimilar is marketed under the names Mynzepli and Afiveg in Europe and as AFLIBERCEPT BS in Japan [5] Group 3: Product Information - AVT06, the biosimilar to Eylea, inhibits vascular endothelial growth factors (VEGF), which are crucial in treating various retinal diseases [5] - Aflibercept remains a widely used treatment for retinal diseases, and Alvotech aims to support its commercial partners in launching the product successfully [3]

Core Insights - Temenos announced the winners of its annual Partner awards, recognizing excellence in driving innovation and customer success within the banking technology sector [1][2]. Partner Awards Summary - **Sales Partner of the Year**: Corebanx, based in Brazil, was recognized for its collaboration with Temenos and its role in securing a major deal for the digital transformation of a leading Brazilian development bank [2]. - **Delivery Partner of the Year**: Capgemini has been a partner for over 20 years, demonstrating high standards in delivery leadership and commitment to training, marking its third consecutive year of receiving this award [3]. - **Technology Partner of the Year**: IBM has supported Temenos offerings for many years, with many customers benefiting from IBM's Power platform and hybrid cloud technology [4]. - **Exchange Partner of the Year**: Lasernet has contributed significantly to referral revenue and has shown exceptional engagement in alignment with Temenos objectives over 15 years [5]. - **Rising Star Partner of the Year**: Accenture has strengthened its collaboration with Temenos, driving significant pipeline opportunities in Europe and adopting a proactive go-to-market model [6]. Company Overview - Temenos is a global leader in banking technology, providing a core banking suite and modular solutions that modernize the banking industry, enabling banks to deliver next-generation services and AI-enhanced experiences [7].

Core Viewpoint - 21shares has launched the 21shares Jito Staked SOL ETP (JSOL), providing liquid access to JitoSOL, a leading liquid staking asset in the Solana ecosystem, allowing investors to gain exposure to Solana's price while earning dual-source staking yields [1][3][4]. Company Overview - 21shares is one of the largest issuers of cryptocurrency exchange-traded products (ETPs) globally, with over 55 ETPs listed across Europe and approximately $8 billion in assets under management [6][8]. - The company aims to bridge the gap between traditional finance and decentralized finance, having launched the world's first physically-backed crypto ETP in 2018 [8]. Product Details - The JSOL ETP allows investors to access JitoSOL through existing banking or brokerage accounts, combining Solana market exposure with liquid staking rewards in a transparent format [2][4]. - JitoSOL is recognized as the dominant liquid staking token on Solana, offering a two-way yield structure that includes standard staking rewards and additional revenue from transaction fees [3][4]. Market Position - Solana has emerged as a preferred blockchain for institutional payments and tokenization, with major firms like Visa, PayPal, and JPMorgan utilizing its network for various financial activities [5]. - The network's high throughput and low transaction costs position it as a viable competitor to Ethereum, supporting real-world economic activities at scale [5]. Strategic Importance - The launch of the JSOL ETP is seen as a significant innovation in the cryptocurrency investment space, enabling European investors to participate in Solana's growth in a regulated manner [4][5]. - The collaboration between 21shares and the Jito Foundation aims to enhance the adoption of Jito's technologies and support the growth of Solana's DeFi ecosystem [10].

Group 1 - Sampo Group will publish its Financial Statement Release for 2025 on 5 February 2026 at approximately 8:30 am Finnish time [1] - The investor presentation and a video review featuring Group CEO Morten Thorsrud will be available on the company's website [1] - A conference call for investors and analysts will take place on 5 February at 10:30 am Finnish time, with registration required for participation [2][3] Group 2 - Key executives including Group CEO Morten Thorsrud, Group CFO Knut Arne Alsaker, and Head of IR Sami Taipalus will attend the conference call [3] - The conference call can be followed live on the company's website, and a recorded version will be accessible later [3] - For further inquiries, Antti Järvenpää, Investor Relations Specialist, is available for media relations [3]

Core Viewpoint - Suominen Corporation is launching a three-year Full Potential Program aimed at improving profitability, targeting a 10% EBITDA by 2028 [1][5][6] Group 1: Full Potential Program - The Full Potential Program is designed to reset profitability and capture improvement opportunities across the organization [2][5] - The program will involve an estimated investment of approximately EUR 30 million over three years, with EUR 10 million allocated for transformation costs and EUR 20 million for capital expenditures to upgrade manufacturing capabilities [6] - The program aims for a leverage ratio of 2x–3x (net debt/EBITDA) by 2028 [6] Group 2: New Operating Model - A new functional operating model will be implemented effective February 1, 2026, focusing on strategic priorities and enhancing accountability [7][10] - The commercial functions will be consolidated to strengthen growth and ensure alignment between R&D and customer management [8] - The role of Chief Operating Officer (COO) will be expanded to oversee all factories, safety, manufacturing engineering, procurement, and supply chain [9] Group 3: Leadership Changes - Kimmo Raunio has been appointed as CFO effective June 1, 2026, bringing extensive experience in driving turnaround and performance improvement initiatives [11][12] - Markku Koivisto has been appointed Chief Commercial and Technology Officer, while Marika Väkiparta has been appointed Chief Strategy and Transformation Officer [12][17] - The leadership changes are aimed at facilitating the transformation and ensuring the company is well-positioned to execute its strategic initiatives [17] Group 4: Company Overview - Suominen manufactures nonwovens as roll goods for wipes and other applications, with net sales of EUR 412.4 million in 2025 and nearly 700 employees in Europe and the Americas [18]

Core Viewpoint - Hiab Corporation will publish its financial statements review for 2025 on February 12, 2026, at 8:00 a.m. EET, with the report available on their website [1] Group 1: Financial Reporting - The financial statements review for 2025 will be published on February 12, 2026 [1] - The report will be accessible at www.hiabgroup.com after its publication [1] Group 2: Conference Details - A live international telephone conference for analysts, investors, and media will take place on the publishing day at 10:00 a.m. EET [2] - The conference will be presented by President and CEO Scott Phillips and CFO Mikko Puolakka [2] - Presentation materials will be available on the website by 9:30 a.m. EET [2] Group 3: Participation Information - Participants can register for the conference via a provided link to receive phone numbers and a conference ID [3] - The event will also be available as a live webcast, with a recording to be published later on Hiab's website [3] Group 4: Company Overview - Hiab is a leading provider of smart and sustainable on-road load-handling solutions, with sales in 2024 totaling approximately EUR 1.6 billion [5] - The company employs over 4,000 people and has a global presence with 3,000 sales and service locations [5]

Core Insights - Suominen Corporation reported unsatisfactory financial performance for the year 2025, with significant declines in net sales and profitability due to challenging market conditions and operational disruptions [1][2][7]. Financial Performance - In Q4 2025, net sales decreased by 19.6% to EUR 95.3 million compared to EUR 118.5 million in Q4 2024 [2][11]. - For the full year 2025, net sales were EUR 412.4 million, down 10.8% from EUR 462.3 million in 2024 [2][13]. - Comparable EBITDA for Q4 2025 was EUR 1.9 million, a decline from EUR 4.2 million in Q4 2024 [2][14]. - The full-year comparable EBITDA was EUR 12.6 million, down from EUR 17.0 million in 2024 [2][18]. - The company reported a loss for the period of EUR 12.1 million for 2025, compared to a loss of EUR 5.3 million in 2024 [20][19]. Operational Challenges - Two significant incidents at US facilities constrained supply capabilities, negatively impacting sales and profitability [7]. - The company faced increased import pressures as US customers sought alternative sources due to supply interruptions [7]. - Cash flow from operations improved to EUR 12.2 million in 2025, compared to EUR 3.9 million in 2024 [2][22]. Strategic Initiatives - Suominen executed strategic initiatives, including investments in a new production line in Alicante, Spain, aimed at enhancing sustainable product capabilities [8]. - A cost-saving program was launched targeting approximately EUR 10 million in benefits over 24 months, with steady implementation in the second half of 2025 [9]. - New products accounted for 24% of net sales in Q4 and 27% for the full year, indicating a focus on innovation [8]. Market Outlook - The nonwovens market is expected to continue its growth trajectory in 2026, with Suominen anticipating an improvement in comparable EBITDA compared to 2025 [3][10]. - The wipes segment is benefiting from the expansion of the moist toilet tissue category in the US, despite market dynamics being affected by excess capacity and global trade flow changes [5][6]. Sustainability Efforts - Suominen is committed to sustainability, aiming for over two-thirds of raw materials to be plant-based and focusing on reducing greenhouse gas emissions in line with the Paris Agreement [27][29]. - The company received a Gold Medal from EcoVadis, placing it in the top 2% of companies in its industry for sustainability performance [32].

Group 1 - Lassila & Tikanoja Plc's three largest shareholders are entitled to appoint representatives to the company's Nomination Board, based on the shareholder register as of January 14, 2026 [1][3] - Two groups of shareholders have agreed to appoint a joint representative to the Nomination Board, including Evald and Hilda Nissi Foundation and Bergholm Heikki as the first group, and Chemec Oy, CH-Polymers Oy, and several members of the Maijala family as the second group [2] - The representatives appointed to the Nomination Board include Juhani Lassila as Chairman and Jukka Leinonen, the Chairman of Lassila & Tikanoja Plc's Board of Directors, as the fourth member [3] Group 2 - The Nomination Board is responsible for preparing proposals for board members and board remuneration for the upcoming Annual General Meeting [4] - Lassila & Tikanoja is a leading Nordic circular economy company focused on waste management, recycling, and promoting sustainable material use, employing approximately 2,300 people in Finland and Sweden [5] - The company is listed on Nasdaq Helsinki and has significant shareholders including Evald and Hilda Nissi Foundation (approximately 11.5% of shares), Miikka Maijala (approximately 9.4% of shares), and Nordea Funds Ltd (approximately 6% of shares) [6]